The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 31 Jul 2007
doi: 10.1242/jcs.03473
Research Article
GSK-3
acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis
Chiou-Feng Lin,
Chia-Ling Chen,
Chi-Wu Chiang,
Ming-Shiou Jan,
Wei-Ching Huang,
and
Yee-Shin Lin*
* Author for correspondence (e-mail: yslin1{at}mail.ncku.edu.tw)
The signaling of glycogen synthase kinase-3
(GSK-3
) has been implicated in stress-induced apoptosis. However, the pro-apoptotic role of GSK-3
is still unclear. Here, we show the involvement of GSK-3
in ceramide-induced mitochondrial apoptosis. Ceramide induced GSK-3
activation via protein dephosphorylation at serine 9. We previously reported that ceramide induced caspase-2 and caspase-8 activation, Bid cleavage, mitochondrial damage, and apoptosis. In this study, we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3
inhibitors lithium chloride and SB216763, and by GSK-3
knockdown using short interfering RNA. We also found that ceramide-activated protein phosphatase 2A (PP2A) indirectly caused GSK-3
activation, and that the PP2A-regulated PI 3-kinase-Akt pathway was involved in GSK-3
activation. These results indicate a role for GSK-3
in ceramide-induced apoptosis, in which GSK-3
acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 and caspase-8.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Escribano, C. Delgado-Martin, and J. L. Rodriguez-Fernandez
CCR7-Dependent Stimulation of Survival in Dendritic Cells Involves Inhibition of GSK3{beta}
J. Immunol.,
November 15, 2009;
183(10):
6282 - 6295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ponnusamy, M. Pang, P. K. Annamaraju, Z. Zhang, R. Gong, Y. E. Chin, and S. Zhuang
Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways
Am J Physiol Renal Physiol,
November 1, 2009;
297(5):
F1361 - F1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Wang, Y.-S. Lin, W.-C. Su, C.-L. Chen, and C.-F. Lin
Glycogen Synthase Kinase-3 and Omi/HtrA2 Induce Annexin A2 Cleavage followed by Cell Cycle Inhibition and Apoptosis
Mol. Biol. Cell,
October 1, 2009;
20(19):
4153 - 4161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Tsai, J.-I. Kai, W.-C. Huang, C.-Y. Wang, Y. Wang, C.-L. Chen, Y.-T. Fang, Y.-S. Lin, R. Anderson, S.-H. Chen, et al.
Glycogen Synthase Kinase-3{beta} Facilitates IFN-{gamma}-Induced STAT1 Activation by Regulating Src Homology-2 Domain-Containing Phosphatase 2
J. Immunol.,
July 15, 2009;
183(2):
856 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-C. Huang, Y.-S. Lin, C.-L. Chen, C.-Y. Wang, W.-H. Chiu, and C.-F. Lin
Glycogen Synthase Kinase-3{beta} Mediates Endoplasmic Reticulum Stress-Induced Lysosomal Apoptosis in Leukemia
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
524 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Guillermet-Guibert, L. Davenne, D. Pchejetski, N. Saint-Laurent, L. Brizuela, C. Guilbeau-Frugier, M.-B. Delisle, O. Cuvillier, C. Susini, and C. Bousquet
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
Mol. Cancer Ther.,
April 1, 2009;
8(4):
809 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mukhopadhyay, S. A. Saddoughi, P. Song, I. Sultan, S. Ponnusamy, C. E. Senkal, C. F. Snook, H. K. Arnold, R. C. Sears, Y. A. Hannun, et al.
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
FASEB J,
March 1, 2009;
23(3):
751 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chen, C.-F. Lin, W.-T. Chang, W.-C. Huang, C.-F. Teng, and Y.-S. Lin
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
Blood,
April 15, 2008;
111(8):
4365 - 4374.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2007